2012 - Europe Direct Iasi

EUROINVENT 2012
4.14.
Title Method for diagnosing the severity of reflux oesophagitis
SCORPAN Anatolie, MD; BIVOL Grigorii, MD; SCURTU
Authors
Alina, MD; SCURTU Serghei, MD;
Institution AGEPI MD
Patent no. Nr.2160/2003
The invention relates to medicine, namely to gastroenterology.
Method for diagnosing the severity of reflux oesophagitis
including by esofagoscopiei, characterized in that it is
determined during propagation peristalticii portion of the
Description esophagus that starts at the spring aorta and ends esogastrice and
reached the junction where the propagation time peristalticii is
6.0 ± 0.3 s, diagnosed mild severity, and 10.80 ± 0.65 - 14.80 ±
0.46 and the average severity and -extremely serious condition of
reflux oesophagitis.
4.15.
Title Method of treatment of chronic C hepatitis
BODRUG Nicolae, MD; RUDIC Valeriu, MD; BUTOROV
Authors Ivan, MD; ANTONOVA Natalia, MD; TIBERNEAC Maia, MD;
ISTRATE Viorel, MD; SCORPAN Anatolie, MD
Institution AGEPI MD
Patent no. Nr. 3477/2008
The invention relates to medicine, namely to hepatology and is
intended for the treatment of chronic hepatitis C.
Method, the invention consists in that it is given 300 ... 400 ml
0.9% NaCl solution ozonated containing 4 ... 5 mg / L ozone,
Description
intravenous drops a day for 10 ... 12 sessions in a series and
simultaneously daily administered spasmolytic, hepatoprotective
amino acids in normal daily dose. After completing the series in
5 ... 6 months is given a hepatoprotective. However, treatment is
performed at least three years.
4.16.
Therapeutic strategies for innovative anti-ageing cosmeceuticals,
Title
based on fully exploitation of three species of Romanian
medicinal plants
Authors Brandusa Dumitriu, Laura Olariu, Lenus Zglimbea
Institution SC Biotehnos SA
Patent no. pending
Description
The correct definition of the cellular / molecular target
for the dermato-cosmetic claim is an important step in cosmetic
product design. In order to fulfill this request, modern techniques
are performed starting with advanced gene research and
continuing with structural protein characterization, intra / extra
cellular signaling pathways, etc. The development of these new
Class 4
81